Use of Polidocanol Endovenous Microfoam to Improve Hemodynamics and Symptomology in Patients with Challenging Clinical Presentations: A Case Series

Davis, Paul; Phillips, John A.; Kolluri, Raghu

doi:10.1016/j.avsg.2018.02.034

Cited by 6 publications

(3 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The full-text reading and application of the inclusion and exclusion criteria resulted in the inclusion of 16 studies in the present systematic review. We excluded 65 studies for the following reasons (Appendix 2): reviews with overlapping data, 7,8 primary outcome not reported, 9–18 not written in English, 19–31 conference abstracts, 32–55 overlapping data with an already included report by same author, 56 data not yet available, 57 full text not available, 58 no distinction between primary and secondary AASV incompetence, 59 no distinction in outcome between GSV and AASV, 60–62 and other outcome. 63–71 A flow chart of the selection procedure is shown in Figure 1.…”

Section: Resultsmentioning

confidence: 99%

A systematic review and meta-analysis of treatment modalities for anterior accessory saphenous vein insufficiency

et al. 2021

View full text Add to dashboard Cite

Objective To investigate and compare the outcomes of the available treatment modalities for anterior accessory saphenous vein (AASV) incompetence. Methods A systematic literature search was performed in MEDLINE, Embase, and the Cochrane Library. Studies reporting the outcomes of patients who were treated for primary AASV incompetence were included. The methodologic quality of the articles was assessed using the Methodological Index for Non-Randomized Studies (MINORS). A random-effects model was used to estimate anatomic success, defined as AASV occlusion. The secondary outcomes were pain during and after treatment, venous clinical severity score, quality of life, esthetic result, time to return to daily activities, and complications. Results The search identified 860 articles, of which 16 met the inclusion criteria. A total of 609 AASVs were reported. The included studies were of poor or moderate quality according to MINORS score. The pooled anatomic success rates were 91.8% after endovenous laser ablation and radiofrequency ablation (EVLA, RFA, 11 studies), 93.6% after cyanoacrylate closure (3 studies), and 79.8% after sclerotherapy (2 studies). The non-pooled anatomic success rate was 97.9% after phlebectomy and 82% after CHIVA. Paresthesia was seen after EVLA in 0.7% of patients (6 studies). Phlebitis was seen in 2.6% of patients after RFA (2 studies), 27% after sclerotherapy (1 study), and 12% after the phlebectomy (1 study). Deep venous thrombosis and skin burn did not occur. Conclusion Treatment of AASV incompetence is safe and effective. Despite limited evidence, occlusion of the AASV can be achieved with endovenous thermal ablation and cyanoacrylate. There does not appear to be a benefit of EVLA compared to RFA regarding treatment efficacy. Phlebectomy shows promising results if the saphenofemoral junction is competent. Lower results are seen after sclerotherapy and CHIVA. However, studies with sufficient sample sizes of solely treatment of AASV incompetence are needed to draw firm conclusions.

show abstract

Section: Resultsmentioning

confidence: 99%

A systematic review and meta-analysis of treatment modalities for anterior accessory saphenous vein insufficiency

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Review ние), которые значимо влияют на качество жизни и приводят к потере работоспособности [6][7][8].…”

Section: обзорunclassified

Treatment of patients with lower limb varicose veins disease

Chernykh¹,

Кубачев²,

Semenov³

et al. 2019

Khir. Z. im. N.I. Pirogova

View full text Add to dashboard Cite

Обзор Review Хронические заболевания вен (ХЗВ) широко распространены и имеют тенденцию к прогрессированию [1-4]. Они охватывают целый каскад патофизиологических последствий венозной гипертонии в нижних конечностях, которые могут иметь различную этиологию. Факторами риска развития ХЗВ являются избыточная масса тела, низкая физическая активность, высокое артериальное давле-ние, пожилой возраст, менопауза, курение, семейный анамнез, женский пол, беременность, снижение мобильности [1-4]. В число признаков ХЗВ нижних конечностей входят экзема, гиперпигментация, венулярная телеангиоэктазия, варикозное расширение вен, отеки и т. д. [4-6]. Симптомы включают различные степени и формы дискомфорта в ногах (боль, отечность, тяжесть, судороги, жже

show abstract

“…To date, several pivotal clinical trials have been published regarding PEM, its safety profile, and its impact on improving patient symptoms and appearance. [4][5][6][7]13,14 However, in these studies, the closure rate was not included as an outcome measure. As a result, it was difficult to compare the published efficacy outcomes of PEM with traditional measures of venous occlusion.…”

mentioning

confidence: 99%

Treatment of superficial venous insufficiency in a large patient cohort with retrograde administration of ultrasound-guided polidocanol endovenous microfoam versus endovenous laser ablation

Deak¹

2022

Journal of Vascular Surgery: Venous and Lymphatic Disorders

View full text Add to dashboard Cite

Use of Polidocanol Endovenous Microfoam to Improve Hemodynamics and Symptomology in Patients with Challenging Clinical Presentations: A Case Series

Cited by 6 publications

References 16 publications

A systematic review and meta-analysis of treatment modalities for anterior accessory saphenous vein insufficiency

A systematic review and meta-analysis of treatment modalities for anterior accessory saphenous vein insufficiency

Treatment of patients with lower limb varicose veins disease

Treatment of superficial venous insufficiency in a large patient cohort with retrograde administration of ultrasound-guided polidocanol endovenous microfoam versus endovenous laser ablation

Contact Info

Product

Resources

About